scispace - formally typeset
R

Russ Chess-Williams

Researcher at Bond University

Publications -  215
Citations -  11685

Russ Chess-Williams is an academic researcher from Bond University. The author has contributed to research in topics: Urothelium & Isoprenaline. The author has an hindex of 36, co-authored 206 publications receiving 10345 citations. Previous affiliations of Russ Chess-Williams include Griffith University & University of Wales.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy

Daniel J. Klionsky, +1287 more
- 01 Apr 2012 - 
TL;DR: These guidelines are presented for the selection and interpretation of methods for use by investigators who aim to examine macroautophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain.

John Garthwaite, +2 more
- 24 Nov 1988 - 
TL;DR: It is reported here that by acting on NMDA (N-methyl-D-aspartate) receptors on cerebellar cells, glutamate induces the release of a diffusible messenger with strikingly similar properties to EDRF that accounts for the cGMP responses that take place following NMDA receptor activation.
Journal ArticleDOI

Urothelium-derived inhibitory factor(s) influences on detrusor muscle contractility in vitro.

M H Hawthorn, +3 more
- 01 Feb 2000 - 
TL;DR: The data suggest the presence of a diffusable, urothelium‐derived inhibitory factor, which could not be identified but appears to be neither nitric oxide, a cyclo‐oxygenase product, a catecholamine, adenosine, GABA nor an EDHF sensitive to apamin.
Journal ArticleDOI

Cellular Effects of Pyocyanin, a Secreted Virulence Factor of Pseudomonas aeruginosa.

Susan Hall, +10 more
- 09 Aug 2016 - 
TL;DR: It has been postulated that, given its chemical properties, PCN is able to readily cross biological membranes, however studies have yet to be undertaken to evaluate this effect, and this review highlights the possible manifestations of PCN exposure.
Journal ArticleDOI

Muscarinic receptors of the urinary bladder: detrusor, urothelial and prejunctional

Russ Chess-Williams
- 01 Jun 2002 - 
TL;DR: Muscarinic receptor antagonists are the main therapeutic agents available for treatment of the overactive bladder, but whether their therapeutic effect involves actions at all three locations (detrusor, prejunctional, urothelial) has yet to be established.